ChartRow logo
Data provided bySource: Twelve Data
THC
$283.33-1.09%
as of close, Nov 6, 2026
☾ AH $283.33 -1.09%
PeersUHSEHCCIENSGHCACNC
Share this page

THC — Tenet Healthcare Corporation price, chart and key statistics

Technical analysis2
Overlay lines0
Addendum charts0
Data provided bySource: Twelve Data
What would $1,000 invested in THC be worth today? →
THC returns: By year · By month · By week · Trailing

Price data

Price
$283.33
YTD price return
+42.58%
YTD total return
+42.58%
Market cap
22.5B
Enterprise value
36.8B
Shares outstanding
79.6M
52W low
$157.58
52W high
$301.44
From 52W high
-6.01%
From 52W low
+79.80%
52W range
87%$158–$301
Beta
1.22

Volume

Rel volume
0.83×
30D volume
763.9K
30D $ vol
206.2M

Insider trading

Insider net 1W
none
Insider net 1M
none
Insider net 3M
−$40.5M
Insider net 1Y
−$62.5M

Form 4 transactions by trade date, as filed; latest on file 2026-09-14.

Fundamentals

Sales (ttm)
22.2B
Sales/share
$278.36
EPS (ttm)
$34.10
FCF (ttm)
3.3B
FCF/share
$41.82
Book value/share
$68.40
Net margin
13.09%
ROE
53.25%
ROA
9.18%
Debt / equity
2.40×
Current ratio
1.58

Growth (CAGR, ttm) · 10Y

Sales
+6.23%+3.19%+2.54%+1.25%
Net income
+114.22%+83.50%+21.86%n/a
FCF
+121.69%+42.99%+23.96%+36.16%
Shares
-9.45%-7.80%-5.77%-2.22%

Per-share growth (CAGR, ttm) · 10Y

EPS
+133.96%+96.93%+27.83%n/a
Sales/share
+17.31%+11.93%+8.82%+3.63%
FCF/share
+144.82%+55.09%+31.56%+39.25%
Book value/share
+49.81%+68.02%+58.97%+29.15%
Price
+38.79%+73.10%+30.29%+31.90%
Total return
+38.79%+73.10%+30.29%+31.90%

Fundamentals end at the last reported quarter; price and total return end at the latest close.

Valuation

P/E (ttm)
8.3×
P/OI (ttm)
4.2×
Fwd P/E
14.0×
P/S (ttm)
1.0×
P/B (mrq)
4.1×
P/FCF (ttm)
6.8×
EV/EBITDA (fy)
5.8×
EV/Sales (ttm)
1.7×
FCF yield (ttm)
14.76%
Buyback yield (realized, 1y)
9.45%
Shareholder yield (realized, 1y)
9.45%
Buyback yield (cash, ttm)
8.04%
Shareholder yield (cash, ttm)
8.04%

Vs own 10Y history

P/E
28th
P/OI
89th
P/S
100th
P/B
35th
P/FCF
47th

Bar = where today’s multiple sits in THC’s own 10-year range:near a decade-low (cheap)→mid-range→near a decade-high (rich).

Performance · price returntotal return · as of 2026-11-06#

Data provided bySource: Twelve Data
1D
-1.09%
5D
+3.69%
1M
+9.62%
3M
+10.40%
YTD
+42.58%
1Y
+38.76%
5Y
+275.67%
1D
-1.09%
5D
+3.69%
1M
+9.62%
3M
+10.40%
YTD
+42.58%
1Y
+38.76%
5Y
+275.67%

Fundamentals#

Revenue

5Y CAGR +3.9%5Y CAGR +3.9%YoY +6.5%
$22.2B TTM$5.6B Q3 '26
FY16FY17FY18FY19FY20FY21FY22FY23FY24FY25TTM
Q1 '17Q2 '17Q3 '17Q4 '17Q1 '18Q2 '18Q3 '18Q4 '18Q1 '19Q2 '19Q3 '19Q4 '19Q1 '20Q2 '20Q3 '20Q4 '20Q1 '21Q2 '21Q3 '21Q4 '21Q1 '22Q2 '22Q3 '22Q4 '22Q1 '23Q2 '23Q3 '23Q4 '23Q1 '24Q2 '24Q3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26

Operating income

5Y CAGR +12.0%10Y CAGR +12.5%YoY +96.9%
$5.4B TTM$1.8B Q3 '26
FY15FY16FY17FY18FY19FY20FY21FY22FY23FY24FY25TTM
Q4 '16Q1 '17Q2 '17Q3 '17Q4 '17Q1 '18Q2 '18Q3 '18Q4 '18Q1 '19Q2 '19Q3 '19Q4 '19Q1 '20Q2 '20Q3 '20Q4 '20Q1 '21Q2 '21Q3 '21Q4 '21Q1 '22Q2 '22Q3 '22Q4 '22Q1 '23Q2 '23Q3 '23Q4 '23Q1 '24Q2 '24Q3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26

EPS (diluted)

5Y CAGR +32.8%10Y n/mYoY +221.5%
$34.10 TTM$12.41 Q3 '26
FY15FY16FY17FY18FY19FY20FY21FY22FY23FY24FY25TTM
Q4 '16Q1 '17Q2 '17Q3 '17Q4 '17Q1 '18Q2 '18Q3 '18Q4 '18Q1 '19Q2 '19Q3 '19Q4 '19Q1 '20Q2 '20Q3 '20Q4 '20Q1 '21Q2 '21Q3 '21Q4 '21Q1 '22Q2 '22Q3 '22Q4 '22Q1 '23Q2 '23Q3 '23Q4 '23Q1 '24Q2 '24Q3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26

Free cash flow

5Y CAGR −2.5%10Y CAGR +30.0%YoY +39.2%
$3.3B TTM$1.1B Q3 '26
FY15FY16FY17FY18FY19FY20FY21FY22FY23FY24FY25TTM

TTM: operating cash flow $4.2B, capex −$910M

Q4 '16Q1 '17Q2 '17Q3 '17Q4 '17Q1 '18Q2 '18Q3 '18Q4 '18Q1 '19Q2 '19Q3 '19Q4 '19Q1 '20Q2 '20Q3 '20Q4 '20Q1 '21Q2 '21Q3 '21Q4 '21Q1 '22Q2 '22Q3 '22Q4 '22Q1 '23Q2 '23Q3 '23Q4 '23Q1 '24Q2 '24Q3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26

Q3 2026: operating cash flow $1.3B, capex −$198M

Shares (diluted)

5Y −14.5%10Y −8.4%YoY −9.0%
85M TTM80.6M Q3 '26
FY15FY16FY17FY18FY19FY20FY21FY22FY23FY24FY25TTM
Q4 '16Q1 '17Q2 '17Q3 '17Q4 '17Q1 '18Q2 '18Q3 '18Q4 '18Q1 '19Q2 '19Q3 '19Q4 '19Q1 '20Q2 '20Q3 '20Q4 '20Q1 '21Q2 '21Q3 '21Q4 '21Q1 '22Q2 '22Q3 '22Q4 '22Q1 '23Q2 '23Q3 '23Q4 '23Q1 '24Q2 '24Q3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26

Net income

5Y CAGR +28.7%10Y n/mYoY +192.4%
$2.9B TTM$1B Q3 '26
FY15FY16FY17FY18FY19FY20FY21FY22FY23FY24FY25TTM
Q4 '16Q1 '17Q2 '17Q3 '17Q4 '17Q1 '18Q2 '18Q3 '18Q4 '18Q1 '19Q2 '19Q3 '19Q4 '19Q1 '20Q2 '20Q3 '20Q4 '20Q1 '21Q2 '21Q3 '21Q4 '21Q1 '22Q2 '22Q3 '22Q4 '22Q1 '23Q2 '23Q3 '23Q4 '23Q1 '24Q2 '24Q3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26
Full THC financials →

Tenet Healthcare Corp. is a diversified healthcare services company focused on delivering hospital care, outpatient treatment, and related support services across the United States. The company operates acute care and specialty hospitals, ambulatory surgery centers, and a broad network of outpatient facilities that provide services such as emergency care, diagnostics, radiology, respiratory therapy, clinical laboratories, and pharmacies. Its business also includes physician services and revenue cycle management through Conifer Health Solutions, which supports hospitals, health systems, physician practices, and employers with administrative and financial operations. Through this combination of inpatient care, ambulatory surgery, and healthcare services infrastructure, Tenet Healthcare Corp. plays an important role in providing coordinated care delivery across multiple settings and patient needs. The company is headquartered in Dallas, Texas.

Dallas, TX·77,000 employees·Medical Care Facilities·tenethealth.com·As of Oct 28, 2026

Recent filings#

All filings and insider trades →

ETFs holding THC#

19 of the 193 ETFs ChartRow carries live hold THC. The 8 largest positions, by the weight each fund filed in its latest SEC N-PORT report (Jun 26 to Aug 26).

FundNameFiled weight
IJHiShares Core S&P Mid-Cap ETF0.4%
MDYSPDR S&P MidCap 400 ETF Trust0.4%
VBRVanguard Small-Cap Value ETF0.3%
VHTVanguard Health Care ETF0.3%
VBVanguard Small-Cap ETF0.2%
VXFVanguard Extended Market ETF0.2%
IWSiShares Russell Mid-Cap Value ETF0.2%
IWRiShares Russell Midcap ETF0.1%
TickerName1M1D
LLYEli Lilly and Company+16.98%-0.79%
JNJJohnson & Johnson+8.42%+1.43%
ABBVAbbVie Inc.+9.23%+1.07%
MRKMerck & Co. Inc.+3.37%-0.14%
UNHUnitedHealth Group Incorporated Common Stock (DE)+4.74%-0.40%
NVSNovartis AG+15.46%+0.38%
TMOThermo Fisher Scientific Inc.+5.81%+2.63%
AMGNAmgen Inc.+14.36%+0.03%